-
Oramed announces publication in diabetes journal
JERUSALEM — Oramed Pharmaceuticals, a developer of oral drug delivery solutions, has published an article in the Journal of Diabetes Science and Technology’s November issue describing evaluation of the company’s glucagon-like peptide (GLP-1) analog formulation (ORMD-0901) in regulating glucose excursions in animal models.
-
Decision Resources: Type 2 diabetes market in China to nearly double by 2014
BURLINGTON, Mass. — A growing drug-treated population will cause the Type 2 diabetes drug market in China to increase to $2.5 billion by 2014, according to a new report by Decision Resources.
The Type 2 diabetes market in China totaled $1.4 billion in 2009, Decision Resources said.